Strs Ohio raised its stake in shares of PAREXEL International Co. (NASDAQ:PRXL) by 218.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 21,000 shares of the medical research company’s stock after buying an additional 14,400 shares during the period. Strs Ohio’s holdings in PAREXEL International were worth $1,825,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in PRXL. Public Employees Retirement System of Ohio increased its stake in shares of PAREXEL International by 4.5% in the first quarter. Public Employees Retirement System of Ohio now owns 1,713 shares of the medical research company’s stock valued at $108,000 after buying an additional 73 shares during the last quarter. Meadow Creek Investment Management LLC increased its stake in shares of PAREXEL International by 7.1% in the first quarter. Meadow Creek Investment Management LLC now owns 1,980 shares of the medical research company’s stock valued at $125,000 after buying an additional 132 shares during the last quarter. Baird Financial Group Inc. increased its stake in shares of PAREXEL International by 2.3% in the first quarter. Baird Financial Group Inc. now owns 5,812 shares of the medical research company’s stock valued at $367,000 after buying an additional 133 shares during the last quarter. Isthmus Partners LLC increased its stake in shares of PAREXEL International by 1.3% in the first quarter. Isthmus Partners LLC now owns 11,516 shares of the medical research company’s stock valued at $727,000 after buying an additional 145 shares during the last quarter. Finally, Capstone Asset Management Co. increased its stake in shares of PAREXEL International by 3.8% in the first quarter. Capstone Asset Management Co. now owns 4,409 shares of the medical research company’s stock valued at $278,000 after buying an additional 160 shares during the last quarter. Hedge funds and other institutional investors own 93.48% of the company’s stock.

PAREXEL International Co. (NASDAQ:PRXL) opened at 87.65 on Friday. The company has a market cap of $4.45 billion, a P/E ratio of 38.53 and a beta of 0.79. The company’s 50 day moving average price is $87.31 and its 200 day moving average price is $73.84. PAREXEL International Co. has a 52-week low of $51.16 and a 52-week high of $87.86.

COPYRIGHT VIOLATION WARNING: “PAREXEL International Co. (NASDAQ:PRXL) Position Increased by Strs Ohio” was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another site, it was copied illegally and reposted in violation of U.S. & international copyright laws. The correct version of this article can be accessed at https://www.watchlistnews.com/parexel-international-co-nasdaqprxl-position-increased-by-strs-ohio/1472084.html.

Several analysts recently weighed in on the company. Zacks Investment Research upgraded PAREXEL International from a “hold” rating to a “buy” rating and set a $98.00 target price for the company in a research note on Tuesday. Barclays PLC downgraded PAREXEL International from an “overweighr” rating to an “equal weight” rating and set a $87.00 target price for the company. in a research note on Tuesday, June 20th. Jefferies Group LLC restated a “hold” rating and set a $88.10 target price on shares of PAREXEL International in a research note on Wednesday, June 21st. Raymond James Financial, Inc. upgraded PAREXEL International from an “underperform” rating to a “mkt perform” rating in a research note on Tuesday, June 20th. Finally, BidaskClub downgraded PAREXEL International from a “strong-buy” rating to a “buy” rating in a research report on Friday, July 28th. Two analysts have rated the stock with a sell rating, nine have given a hold rating and four have assigned a buy rating to the company. PAREXEL International presently has an average rating of “Hold” and a consensus target price of $75.93.

PAREXEL International Company Profile

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries.

Want to see what other hedge funds are holding PRXL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PAREXEL International Co. (NASDAQ:PRXL).

Institutional Ownership by Quarter for PAREXEL International (NASDAQ:PRXL)

Receive News & Ratings for PAREXEL International Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAREXEL International Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.